基于中国期刊全文数据库的我国药物经济学评价研究文献的计量学分析
x

请在关注微信后,向客服人员索取文件

篇名: 基于中国期刊全文数据库的我国药物经济学评价研究文献的计量学分析
TITLE:
摘要: 目的:分析我国药物经济学评价研究的发展现状, 为药物经济学的学科建设提供参考。方法:计算机检索中国期刊全文数据库,检索时限为自建库起至2018年12月,收集以“药物经济学评价”为主题的学术论文,采用文献计量学方法对纳入文献的发表年份、发表期刊、发表机构、文献作者、合作发表、被引文献、关键词等资料进行统计分析。结果与结论:共纳入文献1 197篇,最早的文献发表于1993年,2015年全年发表数最多(104篇),文献来源于289个期刊,其中《中国药房》发表文献数量最多(123篇),第一作者来自619个机构,最多的为中国药科大学(124篇),文献共有作者2 352名,923篇由两位作者及以上完成,合著率为77.1%;作者总人次为3 480人次,合作度为2.91。截至2019年4月19日,975篇文献有被引记录,被引率为81.4%、篇均被引频次为5.83次、H-index为29。文献共有关键词1 922个,出现频次排前三名依次为药物经济学(805次)、成本-效果分析(209次)、药物经济学评价(98次)。本研究结果提示我国的药物经济学评价研究文献发表较早、分布较为广泛、研究内容覆盖全面、部分文献具有较高影响,但是文献总数偏少、分布尚不均衡、核心作者数量不足,相关研究有进一步发展的空间。
ABSTRACT: OBJECTIVE: To analyze the development situation of pharmacoeconomic evaluation research in China, and to provide reference for pharmacoeconomics discipline construction. METHODS: China journal full-text database was searched by computer. The searching time was from database establish to Dec. 2018. After collecting the academic papers with the theme of “pharmacoeconomic evaluation”, statistical analysis was made on publication year, source journals, institutions, authors, cooperation publication, citation information and keywords of papers by bibliometric method. RESULTS & CONCLUSIONS: A total of 1 197 literatures were included. The earliest literature was published in 1993, and the largest number (104 pieces) was published in 2015. The literatures came from 289 journals. Among which, China Pharmacy published the largest number of literatures (123 pieces); the first author came from 619 institutions, which mainly were China Pharmaceutical University (124 pieces); a total of 2 352 authors were involved, and 923 literatures were completed by two or more authors, with co-authorship rate of 77.1%. The total number times of authors was 3 480, and the degree of cooperation was 2.91. As of April 19, 2019, 975 literatures had been cited. The cited rate was 81.4%, the average citation frequency was 5.83 times, and the H-index was 29. There were a total of 1 922 keywords in the literatures, the top three keywords in the list of frequency were pharmacoeconomics (805 times), cost-effectiveness analysis (209 times), and pharmacoeconomic evaluation (98 times). It could be seen that the research literatures on pharmacoeconomic evaluation in China were published earlier and widely distributed; the research content of the literatures was comprehensive, and some literatures had high influence. But the total number of literatures is still small and is distributed unevenly, and the number of core authors is insufficient, and related research needs to be further developed.
期刊: 2019年第30卷第15期
作者: 徐蕴,王庆,黄芳,江星,王会梅,汤大朋
AUTHORS: XU Yun,WANG Qing,HUANG Fang,JIANG Xing,WANG Huimei,TANG Dapeng
关键字: 中国期刊全文数据库;药物经济学评价;研究述评;文献计量学
KEYWORDS: China journal full-text database; Pharmacoeconomic evaluation; Research review; Bibliometrics
阅读数: 74 次
本月下载数: 0 次

* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!